Minority researchers receive AACR awards

12/30/04

PHILADELPHIA -- Each year, the American Association for Cancer Research (AACR) presents awards to minority scholars who have made an impact in cancer research, and show potential to continue to do so in the future.

AACR Minority Scholar Awards in Cancer Research go to full-time graduate or medical students, residents, clinical or postdoctoral fellows, or junior faculty members. Recipients of the awards are chosen on the stipulation that applicants fit the National Cancer Institute definition of groups traditionally underrepresented in cancer and biomedical research. These groups include African Americans, Alaskan Natives, Hispanics, Native Americans, and Native Pacific Islanders.

For Fall 2004 AACR Special Conferences, 44 awards totaling some $80, 000 have been granted. The funds allow early career scientists to attend an AACR Special Conference.

Grants for these awards are provided by the Comprehensive Minority Biomedical Branch of the National Cancer Institute. Scientists are nominated and receive the awards based on their qualifications, references from mentors, and potential professional benefit. Awardees are chosen by an Advisory Committee of the AACR.

Fall 2004 conferences included: Advances in Proteomics in Cancer Research, October 6-10, Key Biscayne, Fla.; Frontiers in Cancer Prevention Research, October 16-20, Seattle, Wash.; The Role of Telomeres and Telomerase in Cancer, November 3-7, San Francisco, Calif.; Chromatin, Chromosomes, and Cancer Epigenetics, November 10-14, Waikoloa, Hawaii; Basic, Translational, and Clinical Advances in Prostate Cancer, November 17-21, Bonita Springs, Fla.; Cell Cycle and Cancer: Pathways and Therapies, December 1-5, Fort Lauderdale, Fla.

Winners of Minority Scholar Awards for participation in the Fall 2004 AACR Special Conferences are listed below.

Advances in Proteomics in Cancer Research, October 6-10, Key Biscayne, Fla. Chevonne D. Eversley, B.S., University of North Carolina, Chapel Hill, N.C.

Frontiers in Cancer Prevention Research, October 16-20, Seattle, Wash.


    Ayoola A. Aboyade-Cole, B.S., Florida A&M University, Tallahassee, Fla.
    Kimberly S. Clay, M.P.H., University of Alabama, Birmingham, Ala.
    Joseph G. Desiderio, B.S., Rutgers, The State University of New Jersey, Piscataway, N.J.
    Jamie M. Dibble, B.S.E.E., University of Arizona, Tucson, Ariz.
    Maria S. Frech, M.S., Lombardi Comprehensive Cancer Center, Washington, D.C.
    Carmen E. Guerra, M.D., University of Pennsylvania, Philadelphia, Pa.
    Aimee M. Johnson, B.S., University of Rochester, Rochester, N.Y.
    Laundette P. Jones, Ph.D., Lombardi Comprehensive Cancer Center, Washington, D.C.
    Marcos B. Paiva, M.D., Ph.D., UCLA School of Medicine, Los Angeles, Calif.
    Marva M. Price, Dr.P.H., Duke University, Durham, N.C.
    Samuel Salinas, B.S., Northern Arizona University, Flagstaff, Ariz.
    Catherine Anne-Marie St. Hill, Ph.D., D.V.M., University of Minnesota, St. Paul, Minn.
    Darlene S. Williams, M.S., Alabama A&M University, Normal, Ala.
    Chantell L. Wilson, M.S., Florida A&M University, Tallahassee, Fla.
    Timothy P. York, Ph.D., Virginia Commonwealth University, Richmond, Va.

The Role of Telomeres and Telomerase in Cancer, November 3-7, San Francisco, Calif.

    Xochitl Cortez-Gonzalez, B.S., University of California, San Diego, La Jolla, Calif.
    Shalmica R. Jackson, Ph.D., University of Texas Southwestern Medical Center, Dallas, Texas.
    Sharla Marion-Ostein Phipps, B.S., University of Alabama at Birmingham, Birmingham, Ala.
    Wallace D. Sharif, Ph.D., University of Texas Southwestern Medical Center, Dallas, Texas.

Chromatin, Chromosomes, and Cancer Epigenetics, November 10-14, Waikoloa, Hawaii

    April J. Adams, B.A., University of Alabama at Birmingham, Birmingham, Ala.
    Marcos R. H. Estecio, Ph.D., UT M. D. Anderson Cancer Center, Houston, Texas.
    Anta'Sha Moni Jones, B.S., Tuskegee University, Tuskegee, Ala.
    Lisa R. McCorvey, B.S., Tuskegee University, Tuskegee, Ala.

Basic, Translational, and Clinical Advances in Prostate Cancer, November 17-21, Bonita Springs, Fla.

    Carlise R. Douglas-Bethel, B.S., University of Maryland, Baltimore, Md.
    Alejandro Jose Garcia, B.A., David Geffen School of Medicine at UCLA, Los Angeles, Calif.
    Tisheeka R. Graham, B.S., Tulane University, New Orleans, La.
    Sandra D. Houser, Ph.D., Cornell University Weill Medical College, New York, N.Y.
    Aymee Perez, Ph.D., University of Miami School of Medicine, Miami, Fla.
    Rita E. Serda, M.S., University of New Mexico, Albuquerque, N.M.

Cell Cycle and Cancer: Pathways and Therapies, December 1-5, Fort Lauderdale, Fla.

    Ayoola Aboyade-Cole, B.S., Florida A&M University, Tallahassee, Fla.
    Selina F. Darling-Reed, Ph.D., Florida A&M University, Tallahassee, Fla.
    Mario R. Green, M.S., Florida A&M University, Tallahassee, Fla.
    Erica L. Kinney, B.S., Purdue University, West Lafayette, Ind.
    Michelle Davila Larrea, B.S., University of Miami, Miami, Fla.
    Everardo Macias, B.S., North Carolina State University, Raleigh, N.C.
    Diana R. Medrano, B.S., UT M. D. Anderson Cancer Center, Houston, Texas
    Michael L. McCaskill, M.P.H., Florida A&M University, Tallahassee, Fla.
    Gustavo Adolfo Miranda-Carboni, Ph.D., David Geffen School of Medicine at UCLA, Los Angeles, Calif.
    Oneil G. Newell, B.S., Florida A&M University, Tallahassee, Fla.
    Onyinye F. Nwagbara, M.S., Florida A&M University, Tallahassee, Fla.
    John T. Powers, B.S., UT M. D. Anderson Cancer Center, Smithville, Texas
    Chantell L. Wilson, M.S., Florida A&M University, Tallahassee, Fla.

Source: Eurekalert & others

Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on PsychCentral.com. All rights reserved.

 

 

No matter how far you have gone on the wrong road, turn back.
-- Turkish proverb